George D. Maynard

662 total citations
25 papers, 451 citations indexed

About

George D. Maynard is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, George D. Maynard has authored 25 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 8 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in George D. Maynard's work include Chemical Synthesis and Analysis (6 papers), Molecular spectroscopy and chirality (6 papers) and Axial and Atropisomeric Chirality Synthesis (5 papers). George D. Maynard is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Molecular spectroscopy and chirality (6 papers) and Axial and Atropisomeric Chirality Synthesis (5 papers). George D. Maynard collaborates with scholars based in United States. George D. Maynard's co-authors include Leo A. Paquette, John H. Kehne, Robin D. Rogers, Christopher K. Cain, Joseph J. Petraitis, Richard R. Harris, W Galbraith, Douglas G. Batt, Neil Pegg and Dana S. Toops and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Brain.

In The Last Decade

George D. Maynard

25 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George D. Maynard United States 13 237 113 89 40 39 25 451
Niall M. Hamilton United Kingdom 13 143 0.6× 240 2.1× 111 1.2× 31 0.8× 17 0.4× 30 467
Umberto Guzzi Italy 12 437 1.8× 233 2.1× 80 0.9× 45 1.1× 17 0.4× 25 703
Lynn Resnick United States 10 136 0.6× 204 1.8× 60 0.7× 57 1.4× 33 0.8× 16 476
Luis Labeaga Spain 18 356 1.5× 170 1.5× 107 1.2× 124 3.1× 20 0.5× 45 878
Sándor Kolok Hungary 14 124 0.5× 210 1.9× 195 2.2× 30 0.8× 10 0.3× 27 424
Fanxing Zeng United States 13 270 1.1× 109 1.0× 136 1.5× 52 1.3× 9 0.2× 25 521
Brian A. Stearns United States 15 581 2.5× 154 1.4× 64 0.7× 92 2.3× 37 0.9× 24 937
Richard T. Beresis United States 15 399 1.7× 228 2.0× 75 0.8× 147 3.7× 21 0.5× 19 602
Chunyang Jin United States 14 170 0.7× 310 2.7× 173 1.9× 29 0.7× 17 0.4× 47 579
Alan Hutchison Switzerland 17 323 1.4× 388 3.4× 228 2.6× 47 1.2× 5 0.1× 24 761

Countries citing papers authored by George D. Maynard

Since Specialization
Citations

This map shows the geographic impact of George D. Maynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George D. Maynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George D. Maynard more than expected).

Fields of papers citing papers by George D. Maynard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George D. Maynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George D. Maynard. The network helps show where George D. Maynard may publish in the future.

Co-authorship network of co-authors of George D. Maynard

This figure shows the co-authorship network connecting the top 25 collaborators of George D. Maynard. A scholar is included among the top collaborators of George D. Maynard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George D. Maynard. George D. Maynard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xingxing, Tianna Zhou, George D. Maynard, et al.. (2020). Nogo receptor decoy promotes recovery and corticospinal growth in non-human primate spinal cord injury. Brain. 143(6). 1697–1713. 37 indexed citations
2.
Million, Mulugeta, Jingfang Zhao, Andrew E. Luckey, et al.. (2013). The Newly Developed CRF1-Receptor Antagonists, NGD 98-2 and NGD 9002, Suppress Acute Stress-Induced Stimulation of Colonic Motor Function and Visceral Hypersensitivity in Rats. PLoS ONE. 8(9). e73749–e73749. 26 indexed citations
3.
Cain, Christopher K., George D. Maynard, & John H. Kehne. (2012). Targeting memory processes with drugs to prevent or cure PTSD. Expert Opinion on Investigational Drugs. 21(9). 1323–1350. 40 indexed citations
4.
Hodgetts, Kevin J., Ping Ge, Tae‐young Yoon, et al.. (2011). Discovery of N-(1-Ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98−2): An Orally Active Corticotropin Releasing Factor-1 (CRF-1) Receptor Antagonist. Journal of Medicinal Chemistry. 54(12). 4187–4206. 11 indexed citations
5.
Rowlett, James K., et al.. (2010). Emergence of anti-conflict effects of zolpidem in rhesus monkeys following extended post-injection intervals. Psychopharmacology. 214(4). 855–862. 3 indexed citations
6.
Wustrow, David J., George D. Maynard, Jun Yuan, et al.. (2008). Aminopyrazine CB1 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 18(11). 3376–3381. 7 indexed citations
7.
Brodbeck, Robbin, Daniel N. Cortright, Jianying Yu, et al.. (2008). Identification and Characterization of NDT 9513727 [N,N-bis(1,3-Benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1 H-imidazole-5-methanamine], a Novel, Orally Bioavailable C5a Receptor Inverse Agonist. Journal of Pharmacology and Experimental Therapeutics. 327(3). 898–909. 27 indexed citations
8.
9.
Maynard, George D., et al.. (1997). Use of CoMFA in validating the conformation used in designing 4-(1H-benzimidazole-2-carbonyl)piperidines with H1/NK1 receptor antagonist activity. Bioorganic & Medicinal Chemistry Letters. 7(22). 2825–2830. 6 indexed citations
10.
Burkholder, Timothy P., et al.. (1996). Identification and chemical synthesis of MDL 105,212, a non-peptide tachykinin antagonist with high affinity for NK1 and NK2 receptors. Bioorganic & Medicinal Chemistry Letters. 6(8). 951–956. 24 indexed citations
11.
12.
Maynard, George D., et al.. (1993). A convergent synthesis of 4-(2-benzothiazoyl)piperidines with antihistamic activity. Bioorganic & Medicinal Chemistry Letters. 3(4). 753–756. 8 indexed citations
13.
Paquette, Leo A. & George D. Maynard. (1992). Relevance of oxyanion stereochemistry to chirality transfer in anionic oxy-Cope rearrangements. Journal of the American Chemical Society. 114(13). 5018–5027. 27 indexed citations
14.
Paquette, Leo A. & George D. Maynard. (1991). Einfluß der Oxido‐Orientierung auf die Stereochemie der anionischen Oxy‐Cope‐Umlagerung. Angewandte Chemie. 103(10). 1392–1394. 4 indexed citations
15.
Paquette, Leo A. & George D. Maynard. (1991). Importance of Oxyanion Orientation to the Stereochemical Control of Anionic Oxy‐Cope Rearrangements. Angewandte Chemie International Edition in English. 30(10). 1368–1370. 12 indexed citations
16.
Paquette, Leo A., Cornelis M. Moorhoff, George D. Maynard, Eugene R. Hickey, & Robin D. Rogers. (1991). Stereochemical course of the base-promoted aldol self-coupling of racemic 5-norbornen-2-one and 2-norbornanone. The Journal of Organic Chemistry. 56(7). 2449–2455. 5 indexed citations
17.
Maynard, George D. & Leo A. Paquette. (1991). Divergent response of a hindered cyclopropene to strong oxidizing agents. The Journal of Organic Chemistry. 56(18). 5480–5482. 13 indexed citations
18.
Batt, Douglas G., et al.. (1990). 2-Substituted-1-naphthols as potent 5-lipoxygenase inhibitors with topical antiinflammatory activity. Journal of Medicinal Chemistry. 33(1). 360–370. 61 indexed citations
19.
Paquette, Leo A., Christopher A. Teleha, Richard T. Taylor, et al.. (1990). Boat/chair topographic stereoselection during anionic oxy-Cope rearrangement of 1-alkenyl-2-cyclopentenyl-endo-norbornan-2-ols. Journal of the American Chemical Society. 112(1). 265–277. 22 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niall M. Hamilton Breakdown of academic impact, for papers by Umberto Guzzi Breakdown of academic impact, for papers by Lynn Resnick Breakdown of academic impact, for papers by Luis Labeaga Breakdown of academic impact, for papers by Sándor Kolok Breakdown of academic impact, for papers by Fanxing Zeng Breakdown of academic impact, for papers by Brian A. Stearns Breakdown of academic impact, for papers by Richard T. Beresis Breakdown of academic impact, for papers by Chunyang Jin Breakdown of academic impact, for papers by Alan Hutchison
Rankless by CCL
2026